Interim data on BioNtech’s/Pfizer’s COVID-19 vaccine candidate BNT162b2 suggest an efficacy of more than 90% -...
COVID-19
Boehringer Ingelheim announced the start of Phase II studies of its oral TRPC6 blocker code-named BI 764198 in...
Siemens Healthineers has launched its Clinitest Rapid COVID-19 Antigen Test in Europe, which can identify...
German biotech companies and their industry association BIO Deutschland have called for appropriate...
Polish Mabion SA and Australian Vaxine Pty Ltd to develop Covax-19
Roche has announced to launch a SARS-CoV-2 point-of-care antigen test this month co-developed with SD...
Immunovative Therapies Ltd and its US subsidiary Mirror Biologics Inc. are testing a novel, T cell-based...
Share
